These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6733806)

  • 1. Antivertigo agents. I. Structure-activity relationships of 2-(2-aminoethyl)pyridines.
    Shiozawa A; Ichikawa Y; Komuro C; Idzu G; Ishikawa M; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):553-63. PubMed ID: 6733806
    [No Abstract]   [Full Text] [Related]  

  • 2. Antivertigo agents. II. Structure-activity relationships of 6-substituted 5,6,7,8-tetrahydro-1,6-naphthyridines.
    Shiozawa A; Ichikawa Y; Ishikawa M; Kogo Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):995-1005. PubMed ID: 6744495
    [No Abstract]   [Full Text] [Related]  

  • 3. Antivertigo agents. IV. Synthesis and antivertigo activity of 6-[omega-(4-aryl-1-piperazinyl)alkyl]-5,6,7,8-tetrahydro-1,6-naphth yridines.
    Shiozawa A; Ichikawa Y; Komuro C; Ishikawa M; Furuta Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):3981-93. PubMed ID: 6529796
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of betahistine dihydrochloride compared with cinnarizine on induced vestibular nystagmus.
    Cullen JR; Hall SJ; Allen RH
    Clin Otolaryngol Allied Sci; 1989 Dec; 14(6):485-7. PubMed ID: 2612026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of betahistine dihydrochloride on induced vestibular nystagmus: a double blind study.
    Oosterveld WJ
    Clin Otolaryngol Allied Sci; 1987 Apr; 12(2):131-5. PubMed ID: 3581491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Hantzsch-type" dihydropyridine hypotensive agents. 3.
    Loev B; Goodman MM; Snader MK; Tedeschi R; Macko E
    J Med Chem; 1974 Sep; 17(9):956-65. PubMed ID: 4859592
    [No Abstract]   [Full Text] [Related]  

  • 7. Definition and antagonism of histamine H 2 -receptors.
    Black JW; Duncan WA; Durant CJ; Ganellin CR; Parsons EM
    Nature; 1972 Apr; 236(5347):385-90. PubMed ID: 4401751
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity relationship of alkylguanidines on smooth muscle organs.
    Ozawa H; Sugawara K
    Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2376-82. PubMed ID: 5719027
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and muscarinic activity of isoxazole-substituted 1,2,5,6-tetrahydropyridines.
    Dannhardt G; Schweiger J; Lambrecht G; Mutschler E
    Arch Pharm (Weinheim); 1994 Nov; 327(11):751-2. PubMed ID: 7840738
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological activity of pyrazo-[3,4-b]-pyridine derivatives. Part I.
    Kuczyński L; Mrozikiewicz A; Banaszkiewicz W; Poreba K
    Pol J Pharmacol Pharm; 1979; 31(3):217-25. PubMed ID: 503970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross tolerance to histamine by the chronic administration of histamine analogues.
    Ambrus JL; Ambrus CM
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):265-72. PubMed ID: 4679852
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of bradykinin antagonists: structure-activity relationships for new categories of antagonist sequences.
    Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1989; 247B():395-400. PubMed ID: 2610083
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker.
    Dodd JH; Schwender CF; Conley RA; Moore JB; Ritchie DM; Fabian AC; Fenk CJ; Bourcet E; Gray-Nunez Y; Kirchner T
    Drug Des Discov; 1993; 10(1):65-75. PubMed ID: 8399994
    [No Abstract]   [Full Text] [Related]  

  • 14. Betahistine HCL antagonism upon neural influence on microcirculation.
    Baez S; Gootman PM; Feldman SM; Orkin LR
    Bibl Anat; 1973; 12():437-42. PubMed ID: 4208230
    [No Abstract]   [Full Text] [Related]  

  • 15. Mini review: smooth muscle pharmacology of substance P.
    Couture R; Regoli D
    Pharmacology; 1982; 24(1):1-25. PubMed ID: 6175001
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of the pharmacology of valyl-beta-(pyrazolyl-3)-L-alanyl6-angiotensin II.
    Hageman WE; Hofmann K; Ertel RJ; Buckley JP
    J Pharmacol Exp Ther; 1969 Aug; 168(2):295-302. PubMed ID: 4308499
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of angiotensin.
    Regoli D; Park WK; Rioux F
    Pharmacol Rev; 1974 Jun; 26(2):69-123. PubMed ID: 4371235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies of cefatrizine (S-640P) (author's transl)].
    Matsuzaki M; Onodera K; Okazaki I; Nakajima A; Kishimoto K
    Jpn J Antibiot; 1976 Jan; 29(1):107-21. PubMed ID: 1263334
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule.
    Weinstock M; Schechter Y; Erez M; Shtacher G
    Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative anticholinergic potencies of R- and S- disopyramide in longitudinal muscle strips from guinea pig ileum.
    Giacomini KM; Cox BM; Blaschke TF
    Life Sci; 1980 Sep; 27(13):1191-7. PubMed ID: 7421405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.